Register entry
- Registered sites
- 0
- Active NDC listings
- 30
- Live patents
- 0
- Shortage listings
- 2
- Countries
- 0
Alert
Drug shortage listings
2| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Bumetanide InjectionCardiovascular | Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2) | Resolved | - | 13 Dec 201730 Sept 2026 |
| Bumetanide InjectionCardiovascular | Bumetanide, Injection, 1 mg/4 mL (0.25 mg/mL) (NDC 83301-0080-2) | Resolved | - | 13 Dec 201730 Sept 2026 |
Catalogue
Drug listings by form and route
3030 active NDC listings: 30 human prescription drug. By marketing category: ANDA 30.
| Dosage form | NDCs |
|---|---|
| injection | 10 |
| capsule | 6 |
| tablet, coated | 5 |
| injection, solution | 4 |
| liquid | 3 |
| tablet, extended release | 2 |
| Route | NDCs |
|---|---|
| intravenous | 13 |
| oral | 13 |
| intramuscular | 4 |
| respiratory (inhalation) | 3 |
| subcutaneous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| mullan pharmaceutical inc. | 30 |
Catalogue
Marketed products
30| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Amikacin Sulfate | Amikacin Sulfate | injection, intramuscular, intravenous | 83301-0022ANDA |
| Amikacin Sulfate | Amikacin Sulfate | injection, intramuscular, intravenous | 83301-0023ANDA |
| Argatroban | Argatroban | injection, intravenous | 83301-0062ANDA |
| Argatroban | Argatroban | injection, intravenous | 83301-0500ANDA |
| Bumetanide | Bumetanide | injection, intramuscular, intravenous | 83301-0080ANDA |
| Bumetanide | Bumetanide | injection, intramuscular, intravenous | 83301-0081ANDA |
| Bupropion Hydrochloride (XL) | Bupropion Hydrochloride | tablet, extended release, oral | 83301-0024ANDA |
| Bupropion Hydrochloride (XL) | Bupropion Hydrochloride | tablet, extended release, oral | 83301-0025ANDA |
| Celecoxib | Celecoxib | capsule, oral | 83301-0011ANDA |
| Celecoxib | Celecoxib | capsule, oral | 83301-0012ANDA |
| Celecoxib | Celecoxib | capsule, oral | 83301-0028ANDA |
| Gabapentin | Gabapentin | tablet, coated, oral | 83301-0001ANDA |
| Gabapentin | Gabapentin | tablet, coated, oral | 83301-0002ANDA |
| Gabapentin | Gabapentin | capsule, oral | 83301-0003ANDA |
| Gabapentin | Gabapentin | capsule, oral | 83301-0004ANDA |
| Gabapentin | Gabapentin | capsule, oral | 83301-0005ANDA |
| Ganirelix Acetate | Ganirelix Acetate | injection, solution, subcutaneous | 83301-0082ANDA |
| Isoflurane, (Volatile for Inhalation) | Isoflurane | liquid, respiratory (inhalation) | 83301-0071ANDA |
| Isoflurane, (Volatile for Inhalation) | Isoflurane | liquid, respiratory (inhalation) | 83301-0072ANDA |
| Labetalol Hydrochloride | Labetalol Hydrochloride | injection, intravenous | 83301-0058ANDA |
| Labetalol Hydrochloride | Labetalol Hydrochloride | injection, intravenous | 83301-0059ANDA |
| Metformin Hydrochloride | Metformin Hydrochloride | tablet, coated, oral | 83301-0008ANDA |
| Metformin Hydrochloride | Metformin Hydrochloride | tablet, coated, oral | 83301-0009ANDA |
| Metformin Hydrochloride | Metformin Hydrochloride | tablet, coated, oral | 83301-0010ANDA |
| Milrinone Lactate | Milrinone Lactate | injection, solution, intravenous | 83301-0016ANDA |
| Milrinone Lactate | Milrinone Lactate | injection, solution, intravenous | 83301-0017ANDA |
| Milrinone Lactate | Milrinone Lactate | injection, solution, intravenous | 83301-0018ANDA |
| Sevoflurane, (Volatile for Inhalation) | Sevoflurane | liquid, respiratory (inhalation) | 83301-0070ANDA |
| Vecuronium Bromide | Vecuronium Bromide | injection, intravenous | 83301-0056ANDA |
| Vecuronium Bromide | Vecuronium Bromide | injection, intravenous | 83301-0057ANDA |
Compare
Other companies listing gabapentin
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Amneal Pharmaceuticals of New York, LLC14 sites · 227 NDC
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Zydus Lifesciences Limited12 sites · 717 NDC
- Olon USA LLC11 sites · 185 NDC
- Glenmark Pharmaceuticals Inc., USA9 sites · 383 NDC
- Granules Pharmaceuticals Inc.8 sites · 302 NDC
- Hetero Labs Limited8 sites · 167 NDC
- CIPLA PHARMACEUTICALS LIMITED7 sites · 368 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
Enquiry
Common questions
- Is Mullan Pharmaceutical Inc. FDA approved?
- Mullan Pharmaceutical Inc. holds no registered establishment of its own; 30 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Mullan Pharmaceutical Inc. make?
- 30 products are listed under Mullan Pharmaceutical Inc. in the openFDA NDC Directory, most often as injection; capsule; tablet, coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.